Shaherose Nanji

Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency.

Carolyn Lutzko, Stephen A. Kruth, Anthony C. G. Abrams‐Ogg et al. · Blood · 1999 · 90 citations

Gene Therapy for Canine alpha-L-Iduronidase Deficiency: In Utero Adoptive Transfer of Genetically Corrected Hematopoietic Progenitors Results in Engraftment but Not Amelioration of Disease

Carolyn Lutzko, Fusayuki Omori, Anthony C. G. Abrams‐Ogg et al. · Human Gene Therapy · 1999 · 53 citations

Engraftment of Gene-Marked Hematopoietic Progenitors in Myeloma Patients after Transplant of Autologous Long-term Marrow Cultures

A. Keith Stewart, D. Robert Sutherland, Shaherose Nanji et al. · Human Gene Therapy · 1999 · 33 citations

Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses

Fusayuki Omori, Carolyn Lutzko, Anthony C. G. Abrams‐Ogg et al. · Experimental Hematology · 1999 · 30 citations · Full text

Developmental Biology, Transplantation, Marrow Transplantation +12

Preclinical Assessment of Human Hematopoietic Progenitor Cell Transduction in Long-Term Marrow Cultures

Ian D. Dubé, Steven Kruth, Anthony C. G. Abrams‐Ogg et al. · Human Gene Therapy · 1996 · 14 citations